Large molecule bioanalysis involves the analysis of complex biomolecules such as proteins, peptides, nucleic acids, and antibodies. It has revolutionized the field of biopharmaceuticals by enabling the characterization, quantification, and assessment of the safety and efficacy of these molecules. Advances in techniques such as mass spectrometry, microfluidics-based platforms, and immunoassays have greatly improved the sensitivity and accuracy of large molecule analysis, ultimately leading to improved patient outcomes.
